维持性血液透析患者FGF23与死亡率的关联:J-DOPPS研究
该研究基于日本透析预后与实践模式研究(J-DOPPS)第5期(2012-2015)1122例维持性血液透析患者,中位透析龄5.8年,中位FGF23水平2113 pg/ml,随访3年154例死亡。校正混杂因素后,FGF23每翻倍与全因死亡风险增加相关(HR 1.12,95%CI 1.03-1.21),但该关联随透析龄延长而减弱,在最高三分位(>9.4年)消失;心血管复合结局呈相似模式。
要点
- 维持性血透患者中,FGF23每翻倍与全因死亡风险增加12%相关(HR 1.12,95%CI 1.03-1.21)。
- FGF23与死亡率的关联随透析龄延长而减弱,透析龄>9.4年者中关联消失。
- 心血管复合结局亦显示透析龄对FGF23效应的修饰作用。
核心结论
- 在维持性血液透析患者中,较高的FGF23水平与全因死亡和心血管复合结局风险增加相关,但该关联在透析龄较长者中减弱并最终消失。
研究设计与样本
- 研究纳入J-DOPPS第5期(2012-2015)1122例有FGF23检测的维持性血液透析患者,采用Cox回归分析FGF23与全因死亡及心血管复合结局的关联。
主要发现
- 入组时中位透析龄5.8年(IQR 2.7-12.4年),中位FGF23水平2113 pg/ml(IQR 583-6880 pg/ml)。
- 3年随访期间1122例中154例死亡。
- 校正后FGF23每翻倍与全因死亡风险增加相关(HR 1.12,95%CI 1.03-1.21)。
- FGF23与死亡的关联随透析龄增加而减弱,在透析龄最高三分位(>9.4年)消失。
- 心血管复合结局及时间依赖模型中也观察到透析龄的类似效应修饰。
临床怎么用
- 对透析龄较短的维持性血透患者,FGF23水平可能有助于死亡风险分层。
- 对透析龄较长(如>9.4年)患者,FGF23的预后价值可能有限,解读时应结合透析龄。
局限性
- 本研究为观察性研究,无法确立因果关系。
- FGF23仅在基线测量,未反映动态变化。
- 研究人群为日本维持性血透患者,结果外推需谨慎。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Elevated fibroblast growth factor 23 (FGF23) levels have been strongly associated with mortality in the predialysis and incident hemodialysis populations, but few studies have examined this relationship in a large cohort of prevalent hemodialysis patients and in particular among persons with high dialysis vintage. To address this, we analyzed data from the Japan Dialysis Outcomes and Practice Patterns Study (J-DOPPS). METHODS: We included 1122 prevalent hemodialysis patients from the J-DOPPS phase 5 (2012-2015) who had FGF23 measurements. We evaluated the association of FGF23 levels with all-cause mortality and cardiovascular composite outcome using Cox regression adjusted for potential confounders. RESULTS: At study enrollment, median dialysis vintage was 5.8 years (interquartile range, 2.7-12.4 years) and median FGF23 level was 2113 pg/ml (interquartile range, 583-6880 pg/ml). During 3-year follow-up, 154 of the 1122 participants died. In adjusted analyses, higher FGF23 was associated with a greater hazard of death (hazard ratio per doubling of FGF23, 1.12; 95% confidence interval, 1.03-1.21); however, the association became weaker as the dialysis vintage increased and finally disappeared in the highest tertile (>9.4 years). Similar patterns of effect modification by dialysis vintage were observed for cardiovascular composite outcome and in time-dependent models. CONCLUSION: Elevated FGF23 was associated with mortality and cardiovascular events in prevalent hemodialysis patients, but the association was attenuated at longer dialysis vintages. This novel finding suggests that long-term hemodialysis patients may be less susceptible to the detrimental effects of FGF23 or correlated biological processes, and additional studies are needed to gain understanding of these possibilities.
引用
- Komaba H, Fuller DS, Taniguchi M, et al. Fibroblast Growth Factor 23 and Mortality Among Prevalent Hemodialysis Patients in the Japan Dialysis Outcomes and Practice Patterns Study. Kidney Int Rep. 2020. PMID: 33163716. doi:10.1016/j.ekir.2020.08.013
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。